Skip to main content
. 2017 Mar 29;17:229. doi: 10.1186/s12885-017-3186-8

Fig. 2.

Fig. 2

Future perspective: Today every patient receives adjuvant chemotherapy after surgical resection, regardless of individual tumor characteristics (a). If it is possible to predict the pattern of failure reliably, tumor treatment can be individualized and linked to biomarker expression patterns. Patients most likely developing metastatic spread might need intensified chemotherapy. Patients developing local recurrence might benefit from localized therapies like radiochemotherapy (b)